Click below to download: Overcoming Assay Inhibition or Enhancement Tech Tip
Overcoming the inhibition and enhancement properties of a product is required by the Food and Drug Administration (FDA) as part of the validation of the LAL test for use in the final release testing of injectables and medical devices.
This Tech Tip focuses on ways to help overcome LAL interference due to inhibition and enhancement. In addition, it provides an overview and examples of use of relevant Lonza products, tested for funtionality and endotoxin content, which will help overcome LAL testing inhibitions, saving customers time and effort .
For additional questions and to learn more, please visit: www.lonza.com/qctestingsupport and contact us via phone or email.